Dry Eye Syndrome Treatment Market: By Treatment Type (Lubricant Eye Drops, Anti-inflammatory Drugs, Autologous Serum Eye Drops, Nutrition supplements), By Disease Type (Evaporative dry eye syndrome, Aqueous dry eye syndrome), By distribution channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others) and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Dry Eye Syndrome Treatment Market Size was valued at USD 5.87 billion in 2022 and expected to reach a value of USD 10.81 billion by 2029, growing at a CAGR of 9.11% during the forecast period 2023-2029. Dry eye syndrome (keratoconjunctivitis sicca), is an ocular disease caused by the lack of tear fluid to lubricate the eyes, which leads to problems in vision, tear film instability, and discomfort causes potential damage to the ocular surface. Dry eye syndrome can also cause due to other ocular surface diseases such as ocular allergy and meibomian gland dysfunction. The ocular surface contains 7 components including lacrimal and accessory lacrimal apparatus. Any abnormalities in one of the ocular surface components may cause the dry eye syndrome. Dry eye syndrome is classified into two types namely, evaporative dry eye and pure aqueous deficiency dry eye. The common symptoms associated with dry eye syndrome include ocular irritation, hyperaemia, mucoid discharge, blurred vision, excessive tearing, ocular dryness, photophobia, and grittiness. Dry eye syndrome is measured by a thin strip of filter paper placed at the edge of the eye, called a Schirmer test to measure the amount of tears present in the eye. Global dry eye syndrome treatment market is in the developing stage owing to increase in the research and development activities by the competitors in the dry eye syndrome treatment market. The patents of various dry eye syndrome treatment drugs are in expiry stage, so various pharmaceutical companies are actively involved in the R&D of new drugs. Some of the key strategies followed by various pharmaceutical companies to increase revenue share in global dry eye syndrome treatment market including acquisitions & mergers, collaborations, and launching of new products.

Dry Eye Syndrome Treatment Market Key Developments:
  • In July 2013, Novaliq GmbH won European approval for its lubricating, drug-delivering eye drop NovaTears, designed for over-the-counter treatment of dry eye syndrome.
  • In June 2015, Allergan plc, a pharmaceutical company acquired Oculeve Inc, a medical device company that focuses on new technologies for dry eye disease to improve market position in the dry eye syndrome treatment market.
  • In January 2017, Novaliq announced the positive top-line results of phase 2 clinical trial evaluating CyclASol in adults with moderate to severe dry eye disease.

Global Dry Eye Syndrome Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.11%

Largest Market

North-America

Fastest Growing Market

Europe
Dry Eye Syndrome Treatment Market Dynamics

The global dry eye syndrome treatment market is expected to grow at a significant CAGR due to rise in the geriatric population (tear glands weaken due to aging and can't produce sufficient tear fluid to maintain a lubricating film over the eyes) and increase in the prevalence of dry eye syndrome. The increase in the prevalence of diabetes, vitamin A deficiency, lupus, thyroid disorders, and rheumatoid arthritis might fuel the dry eye syndrome treatment market. Moreover, increasing awareness among the population about diagnosis and treatment of dry eye syndrome, steady government support for medical research has allowed researchers to treat this condition more precisely and comprehensively, external stimuli such as laser eye surgery, and computer screen overuse are key factors also boosting the dry eye syndrome treatment market over the forecast period. However, expiration of blockbuster drug patents, the popularity of self-medication by patients is the major restraints for the dry eye syndrome treatment market over the forecast period.

Global Dry Eye Syndrome Treatment Market Segmentation

By Treatment
  • Lubricant Eye Drops
    • Preservative-Free Drops
    • Oily Tear Eye Drops
    • Eye Ointments
  • Anti-inflammatory Drugs
    • Corticosteroids
    • Tetracyclines Oral
  • Autologous Serum Eye Drops
  • Nutrition supplements
By Disease
  • Evaporative dry eye syndrome
  • Aqueous dry eye syndrome
By Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Others

Frequently Asked Questions

The dry eye syndrome treatment market is projected to expand at a CAGR of 9.11% during the forecast period

Nicox (France), Allergan (U.S.), Auven Therapeutics (U.S.), Novartis AG (Switzerland), AFT Pharmaceuticals (New Zealand)

North America is the fastest-growing region for dry eye syndrome treatment market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Dry Eye Syndrome Treatment Market Introduction 
2.1.Global Dry Eye Syndrome Treatment Market  - Taxonomy
2.2.Global Dry Eye Syndrome Treatment Market  - Definitions
2.2.1.Treatment
2.2.2.Disease
2.2.3.Distribution Channel
2.2.4.Region
3.Global Dry Eye Syndrome Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Dry Eye Syndrome Treatment Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Dry Eye Syndrome Treatment Market  By Treatment, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Lubricant Eye Drops
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Anti-inflammatory Drugs
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Autologous Serum Eye Drops
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Nutrition supplements
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Dry Eye Syndrome Treatment Market  By Disease, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Evaporative dry eye syndrome
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Aqueous dry eye syndrome
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Dry Eye Syndrome Treatment Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospital pharmacies
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail pharmacies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online pharmacies
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Dry Eye Syndrome Treatment Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Dry Eye Syndrome Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Treatment Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Lubricant Eye Drops
9.1.2.Anti-inflammatory Drugs
9.1.3.Autologous Serum Eye Drops
9.1.4.Nutrition supplements
9.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Evaporative dry eye syndrome
9.2.2.Aqueous dry eye syndrome
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital pharmacies
9.3.2.Retail pharmacies
9.3.3.Online pharmacies
9.3.4.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Dry Eye Syndrome Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Lubricant Eye Drops
10.1.2.Anti-inflammatory Drugs
10.1.3.Autologous Serum Eye Drops
10.1.4.Nutrition supplements
10.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Evaporative dry eye syndrome
10.2.2.Aqueous dry eye syndrome
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital pharmacies
10.3.2.Retail pharmacies
10.3.3.Online pharmacies
10.3.4.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Dry Eye Syndrome Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Lubricant Eye Drops
11.1.2.Anti-inflammatory Drugs
11.1.3.Autologous Serum Eye Drops
11.1.4.Nutrition supplements
11.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Evaporative dry eye syndrome
11.2.2.Aqueous dry eye syndrome
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital pharmacies
11.3.2.Retail pharmacies
11.3.3.Online pharmacies
11.3.4.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Dry Eye Syndrome Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Lubricant Eye Drops
12.1.2.Anti-inflammatory Drugs
12.1.3.Autologous Serum Eye Drops
12.1.4.Nutrition supplements
12.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Evaporative dry eye syndrome
12.2.2.Aqueous dry eye syndrome
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital pharmacies
12.3.2.Retail pharmacies
12.3.3.Online pharmacies
12.3.4.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Dry Eye Syndrome Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Lubricant Eye Drops
13.1.2.Anti-inflammatory Drugs
13.1.3.Autologous Serum Eye Drops
13.1.4.Nutrition supplements
13.2.  Disease Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Evaporative dry eye syndrome
13.2.2.Aqueous dry eye syndrome
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital pharmacies
13.3.2.Retail pharmacies
13.3.3.Online pharmacies
13.3.4.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Novartis AG (Switzerland)
14.2.2.Nicox (France)
14.2.3.Allergan (U.S.)
14.2.4.Santen Pharmaceutical Co., Ltd. (Japan)
14.2.5.Otsuka Holdings Co., Ltd. (Japan)
14.2.6.Auven Therapeutics (U.S.)
14.2.7.AFT Pharmaceuticals (New Zealand)
14.2.8.I-Med Pharma, Inc. (Canada)
14.2.9.Sun Pharmaceuticals Industries Ltd. (India)
14.2.10.Mimetogen Pharmaceuticals (U.S.)
14.2.11.Novaliq GMBH (Germany)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Novartis AG (Switzerland)
  • Nicox (France)
  • Allergan (U.S.)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Otsuka Holdings Co., Ltd. (Japan)
  • Auven Therapeutics (U.S.)
  • AFT Pharmaceuticals (New Zealand)
  • I-Med Pharma, Inc. (Canada)
  • Sun Pharmaceuticals Industries Ltd. (India)
  • Mimetogen Pharmaceuticals (U.S.)
  • Novaliq GMBH (Germany)

Adjacent Markets